International Journal of Drug Policy
Volume 21, Issue 5 , Pages 335-342 , September 2010

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review

  • Lisa Jones

      Affiliations

    • Centre for Public Health, Research Directorate, Faculty of Health and Applied Social Sciences, Liverpool John Moores University, United Kingdom
    • Corresponding Author InformationCorresponding author at: Centre for Public Health, Research Directorate, Faculty of Health and Applied Social Sciences, Liverpool John Moores University, Kingsway House 5th Floor, Hatton Garden, Liverpool L3 2AJ, United Kingdom. Tel.: +44 151 231 8737; fax: +44 151 231 8020.
    • ,
  • Lucy Pickering

      Affiliations

    • School of Health and Social Care, Oxford Brookes University, United Kingdom
    • ,
  • Harry Sumnall

      Affiliations

    • Centre for Public Health, Research Directorate, Faculty of Health and Applied Social Sciences, Liverpool John Moores University, United Kingdom
    • ,
  • James McVeigh

      Affiliations

    • Centre for Public Health, Research Directorate, Faculty of Health and Applied Social Sciences, Liverpool John Moores University, United Kingdom
    • ,
  • Mark A. Bellis

      Affiliations

    • Centre for Public Health, Research Directorate, Faculty of Health and Applied Social Sciences, Liverpool John Moores University, United Kingdom

Received 11 September 2009 ,Revised 28 January 2010 ,Accepted 4 February 2010.

References 

  1. Advisory Council on the Misuse of Drugs . AIDS and drug misuse: Part one. London: Department of Health and Social Security; 1998;
  2. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science and Medicine. 2000;51:1771–1782
  3. Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R, et al. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004;99(9):1136–1146
  4. Burris S, Strathdee SA, Vernick JS. Lethal injections: The law, science and politics of syringe access for injection drug users. University of San Francisco Law Review. 2003;37:813–883
  5. Committee on the Prevention of HIV Infection Among Injecting Drug Users in High-Risk Countries . Preventing HIV infection among injecting drug users in high risk countries: An assessment of the evidence. Washington: National Academies Press; 2006;
  6. Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health. 1997;51:692–697
  7. Des Jarlais DC, Lyles C, Crepaz N The Trend Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The TREND statement. American Journal of Public Health. 2004;94:361–633
  8. Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes. 2003;33(2):199–205
  9. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15(11):1329–1341
  10. Health Protection Agency , Health Protection Scotland , National Public Health Service for Wales , Communicable Disease Surveillance Centre Northern Ireland , Centre for Research on Drugs and Health Behaviour . Shooting up: Infections among injecting drug users in the United Kingdom, 2006. London: Health Protection Agency; 2007;
  11. Health Protection Agency Centre for Infections , Health Protection Scotland , UCL Institute of Child Health . New HIV diagnoses surveillance tables. 2007;<http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1208763421275> Accessed 28.01.10
  12. Huntington S, Hope V, Hutchinson S, Goldberg D, Ncube F. Diversity of needle exchange provision in the UK: Findings from a national survey. Eurosurveillance. 2006;11(32):3022
  13. Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. A review of the effectiveness and cost-effectiveness of needle and syringe programmes for injecting drug users: Final report. Liverpool: Centre for Public Health, Liverpool John Moores University; 2008;<http://www.nice.org.uk/nicemedia/pdf/PH18EffectivenessReviewRevised.pdf>
  14. Khoshnood K, Blankenship KM, Pollack HA, Roan CT, Altice FL. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut. AIDS & Public Policy Journal. 2000;15(3–4):88–94
  15. Kidorf M, Disney E, King V, Kolodner K, Beilenson P, Brooner RK. Challenges in motivating treatment enrollment in community syringe exchange participants. Journal of Urban Health. 2005;82(3):456–467
  16. Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes. 2004;37(2):1307–1312
  17. Lenehan P, Bellis MA, McVeigh J. A study of anabolic steriod use in the North West of England. Journal of Performance Enhancing Drugs. 1996;1:57–70
  18. Masson C, Sorensen J, Perlman D, Shopshire M, Delucchi K, Chen T, et al. Hospital-versus community-based syringe exchange: A randomized controlled trial. AIDS Education & Prevention. 2007;19(2):97–110
  19. McVeigh J, Beynon C, Bellis MA. New challenges for agency based syringe exchange schemes: Analysis of 11 years of data (1991–2001) in Merseyside and Cheshire. International Journal on Drug Policy. 2003;14:399–405
  20. Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. Journal of Urban Health. 2002;79(2):257–265
  21. Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, et al. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Education & Prevention. 2007;19(2):124–136
  22. National Centre in HIV Epidemiology and Clinical Research . HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2008. Sydney, NSW: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2008;
  23. National Institute for Health and Clinical Excellence . Methods for the development of NICE public health guidance. London: National Institute for Health and Clinical Excellence; 2006;
  24. National Treatment Agency for Substance Misuse . The NTA's 2005 survey of needle exchanges in England. London: National Treatment Agency for Substance Misuse; 2007;
  25. Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: An experiment in Marseille, France. American Journal of Public Health. 1999;89(12):1852–1854
  26. Pollack HA, Khoshnood K, Blankenship KM, Altice FL. The impact of needle exchange-based health services on emergency department use. Journal of General Internal Medicine. 2002;17(5):341–348
  27. Rhodes T, Judd A, Mikhailova L, Sarang A, Khutorskoy M, Platt L, et al. Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: Maximizing the protective effects of syringe distribution. Journal of Acquired Immune Deficiency Syndromes. 2004;35(3):293–300
  28. Riley EDS. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. Journal of Acquired Immune Deficiency Syndromes. 2000;24(1):57–61
  29. Singer M, Himmelgreen D, Weeks MR, Radda KE, Martinez R. Changing the environment of AIDS risk: Findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Medical Anthropology. 1997;18(1):107–130
  30. Stimson GV. AIDS and injecting drug use in the United Kingdom, 1987–1993. The policy response and the prevention of an epidemic. Social Science and Medicine. 1995;41(5):699–716
  31. Stimson GV. Has the United Kingdom averted an epidemic of HIV-1 infection amongst drug injectors? Editorial. Addiction. 1996;91(8):1085–1088
  32. Strathdee SA, Ricketts EP, Huettner S, Cornelius L, Bishai D, Havens JR, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug and Alcohol Dependence. 2006;83(3):225–232
  33. Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam cohort studies among drug users. Addiction. 2007;102(9):1454–1462
  34. van den Hoek JA, van Haastrecht HJ, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. American Journal of Public Health. 1989;79(10):1355–1357
  35. Victora CG, Habicht JP, Bryce J. Evidence-based public health: Moving beyond randomized trials. American Journal of Public Health. 2004;94:400–405
  36. Wodak A. Needle exchange and bleach distribution programmes: The Australian experience. International Journal on Drug Policy. 1995;6(1):46–57
  37. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organisation; 2004;
  38. Wodak A, Lurie P. A tale of two countries: Attempts to control HIV among injecting drug users in Australia and the United States. Journal of Drug Issues. 1997;27(1):117–134

PII: S0955-3959(10)00015-0

doi: 10.1016/j.drugpo.2010.02.001

International Journal of Drug Policy
Volume 21, Issue 5 , Pages 335-342 , September 2010

Article Tools

* Image Usage & Resolution